Systemic steroids suppress antimelanocyte antibodies in vitiligo

Journal of Cutaneous Medicine and Surgery

Volumn 1, Issue 4, 1997, Pages 193-195

  Bystryn, Jean Claude ^a  

^a NEW YORK UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIBODY; PREDNISOLONE; STEROID;

ADOLESCENT; ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; FEMALE; HUMAN; MALE; MELANOCYTE; ORAL DRUG ADMINISTRATION; PATHOGENESIS; PIGMENTATION; PRIORITY JOURNAL; SCHOOL CHILD; STEROID THERAPY; VITILIGO;

EID: 0031391591     PISSN: 12034754     EISSN: None     Source Type: Journal    
DOI: 10.1177/120347549700100403     Document Type: Article

References (5)

1. Naughton GK, Eisinger M, Bystryn J-C. Antibodies to normal human melanocytes in vitiligo. J Exp Med 1993; 158:246-251.
2. Naughton GK, Eisinger M, Bystryn J-C. Detection of antibodies to melanocytes in vitiligo by specific immunoprecipitation. J Invest Dermatol 1983; 81:540-542.
3. Bystryn J-C, Naughton GK. The significance of vitiligo antibodies. J Dermatol 1985; 12:1-9.
4. Cui J, Arita Y, Bystryn J-C. Characterization of vitiligo antigens. Pigment Cell Res 1995; 8:53-59.
5. Parischa JS, Khaitan BK. Oral mini-pulse therapy with betamethasone in vitiligo patients having extensive or fast-spreading disease. Int J Dermatol 1993; 32:753-757.